Sublicensing Terms. (a) Novartis will have the right to sublicense any of its rights under Sections 9.2.1.1, 9.2.1.2 and 9.2.1.3 to any of its Affiliates or to any Third Party (which sublicensed rights may be further sublicensable through multiple tiers) without the prior consent of Surface, subject to the requirements of this Section 9.2.1.4.
Appears in 4 contracts
Samples: Collaboration Agreement (Coherus BioSciences, Inc.), Collaboration Agreement (Surface Oncology, Inc.), Collaboration Agreement (Surface Oncology, Inc.)
Sublicensing Terms. (a) 9.1.4.1. Novartis will have the right to sublicense any of its rights under Sections 9.2.1.19.1.1, 9.2.1.2 9.1.2 and 9.2.1.3 9.1.3 to any of its Affiliates or to any Third Party (which sublicensed rights may be further sublicensable through multiple tiers) without the prior consent of Surface, subject to the requirements of this Section 9.2.1.49.1.4.
Appears in 4 contracts
Samples: Collaboration Agreement (Coherus BioSciences, Inc.), Collaboration Agreement (Surface Oncology, Inc.), Collaboration Agreement (Surface Oncology, Inc.)
Sublicensing Terms. (a) 9.3.4.1. Novartis will have the right to sublicense any of its rights under Sections 9.2.1.19.3.1, 9.2.1.2 9.3.2 and 9.2.1.3 9.3.3 to any of its Affiliates or to any Third Party (which sublicensed rights may be further sublicensable through multiple tiers) without the prior consent of Surface, subject to the requirements of this Section 9.2.1.4.9.3.4. β
Appears in 1 contract
Samples: Collaboration Agreement (Coherus BioSciences, Inc.)
